S1 Ep1: FDA Approval Insights: Tivozanib in Relapsed/Refractory Advanced RCC
OncLive® On Air - En podcast av OncLive® On Air
Dr. Rini discusses unique elements of the TIVO-3 trial, the significance of the FDA approval of tivozanib in advanced RCC, and potential next steps for research with the TKI in the paradigm.
